ALPINE IMMUNE SCIENCES INC's ticker is ALPN and the CUSIP is 02083G100. A total of 45 filers reported holding ALPINE IMMUNE SCIENCES INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,759,865 | -91.6% | 153,700 | -92.4% | 1.62% | -86.2% |
| Q2 2023 | $20,864,082 | +33.2% | 2,029,580 | 0.0% | 11.69% | +14.4% |
| Q1 2023 | $15,668,358 | +5.0% | 2,029,580 | 0.0% | 10.22% | +103.2% |
| Q4 2022 | $14,917,413 | +2.1% | 2,029,580 | 0.0% | 5.03% | -6.0% |
| Q3 2022 | $14,613,000 | -15.4% | 2,029,580 | 0.0% | 5.35% | -2.9% |
| Q2 2022 | $17,272,000 | -5.1% | 2,029,580 | 0.0% | 5.51% | +48.0% |
| Q1 2022 | $18,205,000 | -35.2% | 2,029,580 | 0.0% | 3.73% | -6.2% |
| Q4 2021 | $28,110,000 | +29.8% | 2,029,580 | 0.0% | 3.97% | +63.6% |
| Q3 2021 | $21,656,000 | +87.3% | 2,029,580 | +58.0% | 2.43% | +85.6% |
| Q2 2021 | $11,564,000 | -15.1% | 1,284,900 | 0.0% | 1.31% | +1.6% |
| Q1 2021 | $13,620,000 | -15.9% | 1,284,900 | 0.0% | 1.29% | -47.0% |
| Q4 2020 | $16,190,000 | +43.4% | 1,284,900 | 0.0% | 2.43% | -20.5% |
| Q3 2020 | $11,294,000 | – | 1,284,900 | – | 3.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 2,571,450 | $17,640,000 | 4.25% |
| BVF INC/IL | 1,201,717 | $8,244,000 | 0.92% |
| Orbimed Advisors | 3,670,955 | $25,183,000 | 0.39% |
| TIGER MANAGEMENT L.L.C. | 137,728 | $945,000 | 0.26% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 475,450 | $3,262,000 | 0.12% |
| Hikari Power Ltd | 122,972 | $844,000 | 0.09% |
| ALPINE WOODS CAPITAL INVESTORS, LLC | 15,000 | $103,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 35,750 | $245,000 | 0.00% |
| DRW Securities, LLC | 10,000 | $69,000 | 0.00% |
| VICTORY CAPITAL MANAGEMENT INC | 134,542 | $923,000 | 0.00% |